Status:
COMPLETED
Study of the Effects of Artificial Tears on the Response to the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Lead Sponsor:
Mati Therapeutics Inc.
Conditions:
Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine the effect of artificial tears preserved with Benzalkonium Chloride (AT-BAK) on the IOP response to the L-PPDS and to evaluate the safety of the L-PPDS in sub...
Eligibility Criteria
Inclusion
- Over 18 years with ocular hypertension or open-angle glaucoma
- Subjects who have a best-corrected visual acuity of 20/100 or better
Exclusion
- Subjects who wear contact lenses
- Uncontrolled medical conditions
- Subjects with a known sensitivity to latanoprost, BAK, or any other products required for the study
- Subjects requiring chronic topical artificial tears, lubricants, and/or requiring any other chronic topical medications.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00845299
Start Date
January 1 2009
End Date
December 1 2009
Last Update
September 19 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Menlo Park, California, United States, 94025